noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

SIA - Semiconductor Industry[...]

SIA Statement on Senate Commerce Committee Legislation that Funds CHIPS[...]
City of New Orleans, LA

NOPD Releases Video of Suspect in Theft of Plaque Commemorating Tragic Fire
Natera Inc.

Statement of Changes in Beneficial Ownership - Form 4

Healthcare

Newron Pharmaceuticals S.p.A.

04/08/2024 | Press release | Distributed by Public on 04/07/2024 22:56

Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | Newron Pharmaceuticals S.p.A. | News | Health | Securities Issuers | Pharmaceutical Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Six Swiss Exchange | OTC Markets | XETRA | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | SIGMA X MTF | Turquoise

Back

Download the original document